Cellular senescence involves the activation of tumor suppressors, such as the p19ARF-p53-p21 and p16INK4a-pRb pathways, which collectively serve as potent mechanisms inhibiting the development of cancer [2]. This evidence concerns the gene CDKN2A and cancer.